Show simple item record

dc.contributor.authorSoofiyani, SR
dc.contributor.authorHejazi, MS
dc.contributor.authorBaradaran, B
dc.date.accessioned2018-08-26T04:56:15Z
dc.date.available2018-08-26T04:56:15Z
dc.date.issued2017
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/38469
dc.description.abstractCancerous inhibitor of protein phosphatase 2A (CIP2A) is a characterized human oncoprotein that is able to promote cancer cells proliferation, anchorage-independent cell growth and resistance to apoptosis. CIP2A inactivates protein phosphatase 2A (PP2A) which down-regulates Akt (Protein Kinase B) phosphorylation and stabilizes c-Myc (c-Myc oncogene product) in cancer cells. CIP2A has been studied in the most of human malignancies. Here we discuss the role of CIP2A in cancer and give a summary of CIP2A expression in malignancies. Also, where available we indicated the association of CIP2A with the stage of cancers and patients prognosis, explain its localization and the possibility of targeting CIP2A in different cancers.
dc.language.isoEnglish
dc.relation.ispartofBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
dc.subjectAnimals
dc.subjectApoptosis
dc.subjectAutoantigens
dc.subjectBiomarkers, Tumor
dc.subjectCell Line, Tumor
dc.subjectCell Proliferation
dc.subjectHumans
dc.subjectMembrane Proteins
dc.subjectNeoplasms
dc.subjectSignal Transduction
dc.titleThe role of CIP2A in cancer: A review and update.
dc.typearticle
dc.citation.volume96
dc.citation.spage626
dc.citation.epage633
dc.citation.indexPubmed
dc.identifier.DOIhttps://doi.org/10.1016/j.biopha.2017.08.146


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record